Neumora Therapeutics, Inc. - NMRA

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 23
Latest filed: Jun 15, 2026
Form Count
4 9
8-K 5
144 4
SCHEDULE 13G/A 3
SCHEDULE 13D/A 1
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
Jun 15, 2026 8-K Jun 10, 2026 0001193125-26-270328 View
May 29, 2026 8-K May 27, 2026 0001193125-26-248244 View
May 29, 2026 4 May 27, 2026 0001610717-26-000169 View
May 29, 2026 4 May 27, 2026 0001610717-26-000170 View
May 29, 2026 4 May 27, 2026 0001610717-26-000171 View
May 29, 2026 4 May 27, 2026 0001610717-26-000173 View
May 29, 2026 4 May 27, 2026 0001610717-26-000174 View
May 15, 2026 SCHEDULE 13G/A — 0000905148-26-002417 View
May 07, 2026 8-K May 07, 2026 0001193125-26-210310 View
May 04, 2026 SCHEDULE 13G/A — 0002005369-26-000023 View
Apr 01, 2026 SCHEDULE 13D/A — 0001012975-26-000294 View
Mar 30, 2026 8-K Mar 30, 2026 0001193125-26-130372 View
Feb 19, 2026 SCHEDULE 13G — 0002005369-26-000014 View
Feb 19, 2026 4 Feb 17, 2026 0001610717-26-000051 View
Feb 19, 2026 4 Feb 17, 2026 0001610717-26-000052 View
Feb 19, 2026 4 Feb 17, 2026 0001610717-26-000053 View
Feb 19, 2026 4 Feb 17, 2026 0001610717-26-000054 View
Feb 17, 2026 SCHEDULE 13G/A — 0000905148-26-000895 View
Feb 17, 2026 144 — 0001964306-26-000109 View
Feb 17, 2026 144 — 0001964306-26-000110 View
Feb 17, 2026 144 — 0001964306-26-000111 View
Feb 17, 2026 144 — 0001964306-26-000112 View
Feb 11, 2026 8-K Feb 11, 2026 0001193125-26-045526 View